PTJ
RXST icon

Paul Tudor Jones’s RxSight RXST Stock Holding History

Paul Tudor Jones’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Sell
131,736
-19,224
-13% -$116K ﹤0.01% 2697
2026
Q1 		$930K Buy
150,960
+131,655
+682% +$1.09M ﹤0.01% 2420
2025
Q4 		$201K Buy
+19,305
New +$194K ﹤0.01% 3296
2025
Q3 		– Sell
-51,262
Closed -$666K – 3807
2025
Q2 		$666K Sell
51,262
-36,042
-41% -$542K ﹤0.01% 2401
2025
Q1 		$2.2M Buy
87,304
+19,166
+28% +$570K 0.01% 1287
2024
Q4 		$2.34M Buy
68,138
+36,669
+117% +$1.65M 0.01% 1151
2024
Q3 		$1.56M Sell
31,469
-51,647
-62% -$2.65M 0.01% 1363
2024
Q2 		$5M Sell
83,116
-3,886
-4% -$222K 0.03% 664
2024
Q1 		$4.49M Buy
+87,002
New +$4.27M 0.03% 645
2023
Q4 		– Sell
-27,908
Closed -$778K – 2829
2023
Q3 		$778K Sell
27,908
-57,011
-67% -$1.7M 0.01% 1439
2023
Q2 		$2.45M Buy
+84,919
New +$1.89M 0.03% 790

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Paul Tudor Jones's RXST Position: Q2 2026 in Review

Paul Tudor Jones reduced its RxSight (RXST) stake by 13% in Q2 2026, selling an estimated $116K and leaving 131,736 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #2697.

Paul Tudor Jones first reported a position in RXST in Q2 2023 and has held it in 11 quarters since. The position peaked at $5M in Q2 2024. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Paul Tudor Jones held 131,736 shares of RxSight worth $635K as of Q2 2026.
  • Paul Tudor Jones sold 19,224 RxSight shares in Q2 2026, an estimated $116K.
  • RxSight made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2697 holding.
  • Paul Tudor Jones first reported a position in RxSight in Q2 2023 and has held it in 11 quarters since.
  • Paul Tudor Jones's RxSight position peaked at $5M in Q2 2024.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.